David Dietz, PhD, associate professor and chair of pharmacology and toxicology, is senior author on a pair of papers dealing with the study of drug relapse.
Sixty-seven oral and poster presentations were showcased at the 13th annual Neuroscience Research Day of the neuroscience program and the Buffalo Chapter of the Society for Neuroscience (SfN).
Two Jacobs School of Medicine and Biomedical Sciences’ researchers studying how to develop novel, non-addicting painkillers have each been issued awards by the Helping to End Addiction Long-term (HEAL) Initiative, a prestigious and highly competitive program from the National Institutes of Health.
The new program, leading to a Bachelor of Science degree, was developed as a collaboration between the Jacobs School of Medicine and Biomedical Sciences and the College of Arts and Sciences.
Eighty-four student-scientists presented projects during the Ninth Annual Buffalo Summer Research Conference, an interdisciplinary forum marking the culmination of their summer research in Buffalo.
An innovative researcher and others who have made significant contributions to their fields and to the Jacobs School of Medicine and Biomedical Sciences were honored with 2019 Faculty-Staff Recognition Awards.
Jun-Xu Li, MD, PhD, has been awarded a five-year, $2 million National Institutes of Health grant to investigate a novel therapy that may prove more powerful than currently available smoking cessation treatments.
The PhD Program in Biomedical Sciences (PPBS) conducted its third annual white coat ceremony to recognize 19 students from the Class of 2018-2019 — 14 doctoral students and five MD-PhD students — who completed their first year in the program and are moving on to their research laboratory match.
Ten students in the Jacobs School of Medicine and Biomedical Sciences were honored for outstanding achievements during the University at Buffalo’s 2019 Celebration of Student Academic Excellence.
The Jacobs School of Medicine and Biomedical Sciences and UB’s Clinical and Research Institute on Addictions (CRIA) played host to a prestigious Fulbright Enrichment Seminar on the opioid epidemic that brought 79 Fulbright Foreign Students from 51 countries to downtown Buffalo.
